<qa>  What is the main reason for the repeated course?Patients receive oral tipifarnib twice daily on days 1-21 and trastuzumab Herceptin IV over 30-90 minutes on day 1. Courses repeat every 4 weeks in the absence of disease progression or unacceptable toxicity. 